reventing migraines is shaping up to be the drug industry’s next big gold rush, a multibillion-dollar opportunity with four contenders vying to claim its lion’s share. But just which company triumphs will depend on satisfying patients, winning over payers, and — maybe — lining the pockets of doctors.

The key is a protein called CGRP, which plays a role in the dilation of the brain’s blood vessels. Block it and you can prevent the painful, debilitating headaches that plague roughly 40 million Americans, studies have shown. It’s by no means a cure, but doctors say shaving a few headache days off of a migraine sufferer’s monthly burden can make a world of difference.

This is a STAT Plus article and you can unlock it by subscribing to STAT Plus today. It's easy! Your first 30 days are free and if you don't enjoy your subscription you can cancel any time.
Already a subscriber? Log in here.

Leave a Comment

Please enter your name.
Please enter a comment.

  • CGRP-inhibition is a simplistic approach. Read my book on migraine published by Nova Science Publishers, New York, 2009: Adaptive Mechanisms in Migraine. Breaking the Migraine Code, for a comprehensive and realistic grip on migraine.

Sign up for our Morning Rounds newsletter

Your daily dose of what’s new in health and medicine.